Skip navigation links

NIH…Turning Discovery Into Health^®

Follow NCCAM: Read our disclaimer about external links Read our disclaimer about external links

Home
- Contact Us
- Site Map
- FAQs
- Accessibility
- Web Site Policies
- Privacy Policy
Health Info
- Be an Informed Consumer
  - What Is CAM?
  - Safety Information
- For Health Care Professionals
  - Clinical Practice Guidelines
  - Literature Reviews
Research
- NCCAM Research Blog
- Research Results
  - Results by Date
- Sponsored by NCCAM
  Division of Extramural Research
- Conducted at NCCAM
  Division of Intramural Research
Grants & Funding
- What Will NCCAM Fund?
- Types of Grants and Contracts
  - General Award Mechanisms
  - Small Business Research Grant Program (SBIR)
Training
- Training Grant Application, Review, and Award Process
- More Training Resources
- CME/CEU and Online Lectures
News
- NCCAM Clinical Digest
  A monthly newsletter with evidence-based information on CAM and a News condition
About NCCAM
- NCCAM at a Glance
  - Mission and Vision
  - Organizational Structure
- Advisory Council
- Job Opportunities

Questions & Answers: The Phase III Gonzalez Protocol Trial

NIH News

National Institutes of Health

National Center for Complementary and Alternative Medicine (NCCAM)
National Cancer Institute (NCI)

For Immediate Release:

Wednesday, December 1, 1999

Contact

Information missing.

The results of the study are available from the Journal of Clinical Oncology.

Chabot JA, Tsai, W, Fine, RL, et al. Pancreatic Proteolytic Enzyme Therapy Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer. Journal of Clinical Oncology. Epub ahead of print August 17, 2009.

View article summary in the NCI Cancer Bulletin

Background Information:

Gonzalez Regimen (PDQ) (NCI)
Expert-reviewed information summary from the National Cancer Institute about the Gonzalez regimen.
Description of the Study from Clinical Trials (PDQ) (NCI)